Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostaglandin-endoperoxide synthase, commonly known as cyclooxygenase (COX), is a key enzyme responsible for the biosynthesis of prostanoids, including prostaglandins, thromboxanes, and prostacyclins from arachidonic acid. There are two main isoforms: COX-1 (constitutively expressed, involved in homeostatic functions) and COX-2 (inducible, primarily associated with inflammation). Inhibition of COX is the mechanism of action for NSAIDs. COX converts arachidonic acid into PGH2, a precursor for other prostanoids, playing roles in inflammation, vascular tone, thrombosis, and other physiological processes.
Inhibition of cyclooxygenase activity, preventing the synthesis of prostaglandins, thromboxanes, and prostacyclins.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin-Endoperoxide Synthase (Cyclooxygenase) (COX).